Paola De Giorgio

Structure−Affinity Relationship Study on <i>N</i>-[4-(4-Arylpiperazin-1-yl)butyl]arylcarboxamides as Potent and Selective Dopamine D₃ Receptor Ligands

Marcello Leopoldo, Francesco Berardi, Nicola Antonio Colabufo et al. · Journal of Medicinal Chemistry · 2002 · 74 citations · Full text

Structural Modifications of <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-piperazinehexanamides: Influence on Lipophilicity and 5-HT₇ Receptor Activity. Part III

Marcello Leopoldo, Enza Lacivita, Paola De Giorgio et al. · Journal of Medicinal Chemistry · 2008 · 67 citations · Full text

Drug Target, Part Iii, Pharmacotherapy +18

Determination of 1-aryl-4-propylpiperazine pKa values: The substituent on aryl modulates basicity

Enza Lacivita, Marcello Leopoldo, Paola De Giorgio et al. · Bioorganic & Medicinal Chemistry · 2008 · 47 citations

1-Aryl-4-propylpiperazine Pka Values, Biochemistry, Medicine +5

Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin₇ (5-HT₇) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo

Enza Lacivita, Daniela Patarnello, Nikolas Stroth et al. · Journal of Medicinal Chemistry · 2012 · 38 citations · Full text

Antagonist Action, Psychopharmacology, Peptide Science +18

Design, Synthesis, and Binding Affinities of Potential Positron Emission Tomography (PET) Ligands for Visualization of Brain Dopamine D₃Receptors

Marcello Leopoldo, Enza Lacivita, Paola De Giorgio et al. · Journal of Medicinal Chemistry · 2005 · 31 citations · Full text